LinksHomepageStock List Search by Ticker News Login |
Eli Lilly And Company (NYSE:LLY)
|
|
The following stock analysis is based on 10.4 years of data (i.e. since Oct 31, 2012). All the stock history has been downloaded.
Eli Lilly And Company trades on the NYSE exchange in USD dollars.
It is in the sector.
It is currently trading at $340.69 ($335.87 the previous day).It pays a 1.17% dividend.
The next reporting date is in 27 days (2023 04 27).
CNN estimates profits for the upcoming quarter will be $1.76 per share ($6.8B). The current Canada / US exchange rate is 1.3521.
Over the past 12 months, $375107899 worth of shares have been purchased and $1104840637 worth of shares have been sold by insiders.
The year over year average increase is 34.8% per year assuming steady exponential growth. The actual 5 year average is 32.04. Details on the individual increase in one year intervals is provided below.
| Past Performance | Average Price | Percent Change | |
|---|---|---|---|
| 1 year | 324.50192735849 | 36.9 | + Above Average |
| 2 year | 237.05923423423 | 45.5 | + Above Average |
| 3 year | 162.89940465116 | 37.3 | + Above Average |
| 4 year | 118.67948238994 | 13.4 | - Below Average |
| 5 year | 104.70072243346 | 27.1 | - Below Average |
The worst drop it has had in recent years is -26.7%. It has a shape to the stock curve, which means
| DAYS AG0 | PRICE | |
| 10 | 327.07 | RISING |
| 30 | 323.06 | RISING |
| 60 | 345.54 | DROPPING |
| 150 | 357.86 | DROPPING |
| 365 | 289.02 | RISING |
| 800 | 185.68 | RISING |
| 1200 | 119.64 | RISING |
| 1600 | 110.1 | RISING |
| 2000 | 86.96 | RISING |
CORRECTED-UPDATE 1-FOCUS-US doctor groups debate best use of new weight-loss drugsThu, 30 Mar 2023 15:01:29 As powerful new obesity drugs enter the U.S. market, medical associations are keen to advise their members on how to best use them for patients. And some are considering more complex, patient-specific assessments to determine the best course of ...... Read Full Article |
3 Stocks That Could Benefit From the Ozempic CrazeThu, 30 Mar 2023 13:45:00 Ozempic is a drug that has been soaring in popularity over the past year. Three companies that can benefit from the excitement around this weight-loss treatments are Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), and WW International (NASDAQ: WW). ...... Read Full Article |
CORRECTED-FOCUS-US doctor groups debate best use of new weight-loss drugsThu, 30 Mar 2023 11:00:00 As powerful new obesity drugs enter the U.S. market, medical associations are keen to advise their members on how to best use them for patients. And some are considering more complex, patient-specific assessments to determine the best course of ...... Read Full Article |
Novo Hits Another Record High As WHO Considers A Key Move In ObesityWed, 29 Mar 2023 20:10:40 The World Health Organization will consider adding obesity treatments to its "essential medicines list." The move could help some drug stocks.... Read Full Article |
Novo Nordisk's Obesity Drug May Find Place On World Health Organization's 'Essential Medicines List'Wed, 29 Mar 2023 19:07:45 For the first time World Health Organization is reportedly considering adding obesity drugs to its "essential medicines list," used to guide government purchasing decisions in low- and middle-income countries, the U.N. agency. A panel of advisers to the WHO ...... Read Full Article |
3 Dividend Stocks That Have Been Paying Investors Since the 1800sWed, 29 Mar 2023 13:00:00 Three businesses that have not only been around for more than a century but have also been paying dividends going back to the 1800s are Eli Lilly (NYSE: LLY), ExxonMobil (NYSE: XOM), and the Toronto-Dominion Bank (NYSE: TD). Healthcare giant ...... Read Full Article |
UPDATE 1-Boehringer's profit up as Jardiance gains offset higher costsWed, 29 Mar 2023 12:01:00 German unlisted drugmaker Boehringer Ingelheim said on Wednesday its operating income rose 1.4% in 2022, as more prescriptions of diabetes drug Jardiance trumped higher energy and development costs. Family-owned Boehringer said in its annual report that full-year operating income came in at 4.77 ...... Read Full Article |
A Eli Lilly and Company (NYSE:LLY) insider increased their holdings by 1.4% last yearWed, 29 Mar 2023 12:00:16 From what we can see, insiders were net buyers in Eli Lilly and Company's ( NYSE:LLY ) during the past 12 months. That...... Read Full Article |
Boehringer's profit up 1.4% as Jardiance gains offset impairmentsWed, 29 Mar 2023 09:08:05 German unlisted drugmaker Boehringer Ingelheim said on Wednesday its operating income rose 1.4% in 2022, as more prescriptions of diabetes drug Jardiance trumped higher energy costs and the effect of write-downs on development projects. Family-owned Boehringer said in its annual report that ...... Read Full Article |
Eli Lilly (LLY) Gains As Market Dips: What You Should KnowTue, 28 Mar 2023 21:45:09 In the latest trading session, Eli Lilly (LLY) closed at $337.65, marking a +0.91% move from the previous day.... Read Full Article |
Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now?Tue, 28 Mar 2023 14:15:00 While growth stocks boomed in the era of easy money, value stocks have returned to form as the market's top performers in the current high interest rate environment. Now, value comes in many forms, such as a highly dependable dividend, ...... Read Full Article |
Novartis Surges As It Goes After Eli Lilly's Second Biggest MoneymakerMon, 27 Mar 2023 20:04:11 Novartis stock surged Monday after the company's treatment reduced the risk of relapse in patients with early-stage breast cancer.... Read Full Article |
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical NamesMon, 27 Mar 2023 13:00:01 Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.... Read Full Article |
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli LillyMon, 27 Mar 2023 11:41:11 Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog.... Read Full Article |
Who Are Pfizer's (PFE) Main Competitors?Sat, 25 Mar 2023 17:38:05 Pfizer's biggest competitors in the global pharmaceutical industry are Johnson and Johnson, Roche, Eli Lilly, AbbVie, Novo Nordisk, and Merck.... Read Full Article |
US FDA seeks more rigorous trials for cancer drugs' accelerated nodFri, 24 Mar 2023 15:02:21 The U.S. health regulator on Friday proposed cancer drug developers conduct more rigorous trials in order to seek accelerated approval for their therapy candidates. The Food and Drug Administration proposed using the gold-standard "randomized controlled trials" (RCT) where patients ...... Read Full Article |
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRLFri, 24 Mar 2023 13:04:01 Sanofi's (SNY) Dupixent succeeds in a pivotal study for COPD. FDA gives CRL to AbbVie's (ABBV) Parkinson's disease therapy, ABBV-951... Read Full Article |
The Zacks Analyst Blog Highlights Lilly, Honeywell International. American Express, Lowe's Companies and AirbnbFri, 24 Mar 2023 11:13:11 Lilly, Honeywell International. American Express, Lowe's Companies and Airbnb are part of the Zacks top Analyst Blog.... Read Full Article |
If EPS Growth Is Important To You, Eli Lilly (NYSE:LLY) Presents An OpportunityFri, 24 Mar 2023 11:00:36 Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...... Read Full Article |
Top Analyst Reports for Eli Lilly, Honeywell International and American ExpressThu, 23 Mar 2023 19:12:07 Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), Honeywell International Inc. (HON) and American Express Co. (AXP).... Read Full Article |